Abeona Therapeutics (ABEO) Short term Debt (2016 - 2025)
Historic Short term Debt for Abeona Therapeutics (ABEO) over the last 11 years, with Q3 2025 value amounting to $8.9 million.
- Abeona Therapeutics' Short term Debt rose 10002.25% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 10002.25%. This contributed to the annual value of $5.9 million for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2025, Abeona Therapeutics' Short term Debt is $8.9 million, which was up 10002.25% from $5.6 million recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Short term Debt registered a high of $34.4 million during Q2 2021, and its lowest value of $2.2 million during Q2 2024.
- Moreover, its 4-year median value for Short term Debt was $5.6 million (2025), whereas its average is $10.9 million.
- In the last 5 years, Abeona Therapeutics' Short term Debt plummeted by 8600.8% in 2022 and then surged by 15004.5% in 2025.
- Over the past 4 years, Abeona Therapeutics' Short term Debt (Quarter) stood at $4.6 million in 2021, then grew by 7.0% to $4.9 million in 2022, then grew by 20.42% to $5.9 million in 2024, then skyrocketed by 50.0% to $8.9 million in 2025.
- Its last three reported values are $8.9 million in Q3 2025, $5.6 million for Q2 2025, and $8.1 million during Q1 2025.